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Background: blaCTX-M-15, the most widely distributed gene encoding extended-spectrum β-lactamases globally, was
not common in China. This study was performed to characterize blaCTX-M-15-carrying Escherichia coli in western China.
Findings: Out of 144 Escherichia coli isolates from 20 hospitals in western China, 8 were found carrying blaCTX-M-15.
blaCTX-M-15 was carried by isolates of ST131and 5 new STs (ST3342, ST3513, ST3516, ST3517 and ST3518). The 5 new STs
shared 5 identical alleles out of 7 but only had up to 2 alleles identical to ST131. blaCTX-M-15 was located on plasmids of
IncI1 (ST16) or IncFII-related group (four replicon types). The co-transfer of a few antimicrobial resistance genes includ-
ing qnrA, qnrB, qnrS, qepA, aac (6′)-Ib-cr, aac (3)-II, tetA, blaTEM and blaOXA-1 with blaCTX-M-15 were examined but only bla-
TEM-1 was found co-transferring with blaCTX-M-15.
Conclusions: Five new STs of E. coli and three new types of IncFII-related plasmids carrying blaCTX-M-15 were identified.
This study together with several reports suggested that blaCTX-M-15 has emerged in China and the interruption of both
vertical and horizontal transmission of blaCTX-M-15 is required to hurdle its further spread.
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Escherichia coli producing extended-spectrum β-lactamases
(ESBLs) is a challenge for clinical treatment and infection
control. blaCTX-M-15 has emerged as the most widely
distributed gene encoding ESBLs globally, but it was
not common in China [1]. We performed a snapshot
survey on the molecular epidemiology of E. coli carry-
ing blaCTX-M-15 in Sichuan province, western China.
All non-duplicated E. coli clinical isolates (n = 144)
that were recovered in 20 hospitals in Sichuan, western
China, from June 22 to 25, 2011 were collected regard-
less of their antimicrobial susceptibility profiles and
types of infections. The presence of blaCTX-M genes were
detected using both a single PCR with universal primers
CTX-U1/U2 and a multiplex PCR [2,3] and 25.7% (37/144)
isolates were found carrying blaCTX-M. A total of 17 iso-
lates had a blaCTX-M gene belonging to the blaCTX-M-1* Correspondence: zongzhiy@scu.edu.cn
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reproduction in any medium, provided the orgroup and the complete sequence of the blaCTX-M-1-like
gene in all 17 isolates was obtained using PCR with
primers ISEcp1IR-F and orf477-R [4]. Sequencing revealed
blaCTX-M-15 in 8 isolates, corresponding to 21.6% of
blaCTX-M variants, and the remaining 9 isolates had either
blaCTX-M-55 (n = 8) or blaCTX-M-57 (n = 1). The 8 isolates
carrying blaCTX-M-15 were from urine (n = 5), sputum (n = 2)
and ascites (Table 1). Although blaCTX-M-15 has become
the dominant gene encoding ESBLs in many countries
and E. coli of ST131 carrying blaCTX-M-15 was widely dis-
tributed [5], blaCTX-M-15 had only been occasionally found
in isolates recovered before 2007 in China [1]. However,
several studies on E. coli isolates obtained in 2007 and
afterwards in China have found that blaCTX-M-15
accounted to 14% to 24% of blaCTX-M variants detected
from human [6,7]. The present study and previous reports
therefore suggested the emergence of E. coli carrying
blaCTX-M-15 in China in recent 5 years.
Six of the isolates carrying blaCTX-M-15 belonged to the
phylogenetic group B2 and the remaining two were of
group A1 and D, respectively, determined as described
previously [8] (Table 1). Using multi-locus sequenceLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Molecular characteristics of 8 E. coli isolates carrying blaCTX-M-15
Isolate Source ST Phylogenetic
group
Inc group1 pMLST/RST1 Additional resistance genes3
A63 urine 3513 A FIIA F31:A-:B- blaTEM, aac (3)-II
H9 urine 3342 D FIIA FIA FIB F1:A2:B1 blaTEM, aac (3)-II, aac (6′)-Ib-cr
D57 urine 3516 B2 FIIA FIA FIB F1:A2:B20 blaTEM, aac (3)-II
W19 urine 131 B2 FIIA F2:A-:B- blaTEM, qnrS
V12 sputum 3518 B2 I1 1-ND2-10-ND2-6
I10 sputum 3517 B2 I1 ST16 (1-5-10-8-6) blaTEM, aac (3)-II
U35 urine 131 B2 I1 ST16 (1-5-10-8-6) qnrS
I20 ascites 131 B2 I1 ST16 (1-5-10-8-6) aac (3)-II
1Inc, incompatibility; Inc group and pMLST/RST results are for plasmids carrying blaCTX-M-15.
The allele number of the IncI1 pMLST profile (repI, ardA, trbA, sogS and pill) is indicated.
2ND, not determined.
3Resistance genes that were co-transferred with blaCTX-M-15 are in bold.
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were assigned to 6 sequence types (ST) including ST131
and 5 new STs (Table 1). Of note, E. coli of ST131 was
found carrying blaCTX-M-3, −14 and −65 but not −15 in our
local settings previously [10]. This study demonstrated
the emergence of the globally-spread ST131 carrying
blaCTX-M-15 in our region. The 5 new STs (ST3342,
ST3513, ST3516, ST3517 and ST3518) shared 5 identical
alleles (gyrB, icd, mdh, purA and recA) out of 7 and
these STs might therefore belong to a common clonal
complex. In contrast, the 5 STs had only up to 2 alleles
identical to ST131, suggesting the 5 STs and ST131 had
different clonal origins.
Self-transmissible plasmids carrying blaCTX-M-15 were
obtained from 7 out of the 8 isolates using mating as de-
scribed previously [4]. The remaining isolate V12 did
not yield transconjugants carrying blaCTX-M-15 despite
repeated attempts but transformants carrying blaCTX-M-15
were obtained from V12 by electroporation with plasmids
prepared using alkaline lysis [11]. This suggests that
blaCTX-M-15 was carried by a non-conjugative plasmid in
isolate V12. Plasmids carrying blaCTX-M-15 were prepared
using alkaline lysis and were subjected to PCR-based repli-
con typing [12]. Four plasmids were of IncI1 and the other
four belonged to the IncFII-related group, two of which
contained replicons of IncFIA and IncFIB in addition to
the IncFII-related replicon. IncF plasmid replicons se-
quence typing (RST) [13] and IncI1 plasmid MLST
(pMLST) [14] were employed to investigate the related-
ness of these plasmids carrying blaCTX-M-15 (Table 1). All
of the IncI1 plasmids except the non-conjugative one from
isolate V12 were of ST16 (1-5-10-8-6). According to the
IncI1 pMLST database (http://pubmlst.org/plasmid/),
ST16 IncI1 plasmids have been found carrying blaCTX-M-15
in isolates from cattle in the UK but were not found in
human isolates carrying blaCTX-M-15 before. The identifi-
cation of ST16 IncI1 plasmids in both cattle and humanisolates suggested the transfer of blaCTX-M-15 between ani-
mal and human, which implicates that the control of the
transmission of blaCTX-M-15 should address sources be-
yond human. Two alleles, ardA and sogS, both of which
are associated with conjugation, were unable to be ampli-
fied from the non-conjugative plasmid (pV12) carrying
blaCTX-M-15 from isolate V12. Therefore, the ST could not
be assigned for pV12 but the remaining three alleles of
pV12 were identical to those of ST16, suggesting that
pV12 might be derived from a ST16 IncI1 plasmid. Four
different RST profiles were present for the four IncF plas-
mids carrying blaCTX-M-15, suggesting that the spread of
blaCTX-M-15 in our local settings might have been medi-
ated by multiple IncF plasmids. Among the four RST
types of IncF plasmids identified here, F2:A-:B- plasmids
carrying blaCTX-M-15 appeared to be widely distributed
and have been found in Canada, France, Italy and the UK
(http://pubmlst.org/plasmid/), while the remaining three
types, F1:A2:B1, F1:A2:B20 and F31:A-:B- have not been
deposited in the RST database, representing new IncF
RST types.
The co-transfer of a few antimicrobial resistance genes
including qnrA, qnrB, qnrS, qepA, aac(6′)-Ib-cr, aac(3)-II,
tetA, blaTEM and blaOXA-1 with blaCTX-M-15 were exam-
ined for transconjugants and transformants by PCR. Un-
like previous studies, the co-transfer of resistance genes
with blaCTX-M-15 except for blaTEM-1 was not common in
this study (Table 1).
In summary, although blaCTX-M-14 was the most com-
mon blaCTX-M variant in China, the present study together
with recent reports [6,7] suggested that blaCTX-M-15 has
emerged in China. The prevalence of blaCTX-M-15-carrying
isolates would compromise the efficacy of the widely-used
broad-spectrum cephalosporins and therefore represents a
serious challenge for clinical treatment and public health.
The spread of blaCTX-M-15 in our local settings is mediated
by two clonal complexes and by self-transmissible
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http://www.ann-clinmicrob.com/content/12/1/35plasmids of IncI1 or IncF. The spread of isolates carrying
blaCTX-M-15 in China warrants more studies. The interrup-
tion of both vertical and horizontal transmission of
blaCTX-M-15 using infection control measures such as
standard precautions and contact precautions appear to
be the key to hurdle the further spread of this antimicro-
bial resistance determinant.
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